Apex Healthcare Berhad Stock Forecast for 2023 - 2025 - 2030

Updated on 04/19/2024

Stock Rating
18
Price Target
RM2.64
Consensus
Neutral
Downside
-12.00%
Analysts
0
Stock Rating
18
Downside
-12.00%
Analysts
0
Price Target
RM2.64

Apex Healthcare Berhad Stock Forecast and Price Target

Apex Healthcare Berhad's most recent price target of RM2.64 for 2024 was provided by renowned analysts over the past few months, with an average prediction of RM2.64. If this prediction is correct, Apex Healthcare Berhad's stock could fall by -12 percent from its current trading price. The potential decrease for the stock is RM2.64 per share, with a possible range of RM2.40 to RM2.90. If you're not interested in AHEALTH stock, you may be interested in its competitors.

RM2.64

-12.00% Downside

Hold
Hold

Apex Healthcare Berhad Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Apex Healthcare Berhad's Price has decreased by 100.00%, going from RM2.10 to RM0.00. In the next year, analysts believe that Fair Value will reach RM3.42 – an increase of 100.00%. For the next seven years, experts predict that Apex Healthcare Berhad's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
RM3.42
2025 Fair Value Forecast
RM3.68
2026 Fair Value Forecast
RM3.94
2027 Fair Value Forecast
RM2.45
2028 Fair Value Forecast
RM2.83
2029 Fair Value Forecast
RM3.22
2030 Fair Value Forecast
RM3.60
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DPHARMA Stock Forecast Duopharma Biotech Berhad Buy 17
RM1.16 Buy/Sell RM1.48 28.45%
KOTRA Stock Forecast Kotra Industries Berhad Outperform 16
RM4.70 Buy/Sell RM5.79 14.89%
YSPSAH Stock Forecast Y.S.P. Southeast Asia Holding ... - 6
RM2.43 Buy/Sell RM3.00 -100.00%
NOVA Stock Forecast Nova Wellness Group Berhad Outperform 16
RM0.52 Buy/Sell RM0.72 30.77%
RHONEMA Stock Forecast Rhone Ma Holdings Berhad Hold 0
RM0.66 Buy/Sell RM0.68 3.03%

Apex Healthcare Berhad Revenue Forecast for 2023 - 2025 - 2030

Apex Healthcare Berhad's Revenue has grown In the last three years, rising from RM698.73M to RM936.17M – a growth of 33.98%. In the next year, analysts believe that Revenue will reach RM994.33M – an increase of 6.21%. For the next seven years, experts predict that Apex Healthcare Berhad's Revenue will grow at a rate of 6.92%.

2024 Rev Forecast
RM0.99B
2025 Rev Forecast
RM1.05B
2026 Rev Forecast
RM0.99B
2027 Rev Forecast
RM0.97B
2028 Rev Forecast
RM0.98B
2029 Rev Forecast
RM1.01B
2030 Rev Forecast
RM1.00B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SUNZEN Stock Forecast Sunzen Biotech Berhad - 0
RM0.28 Buy/Sell RM0.00 -100.00%
BIOHLDG Stock Forecast Bioalpha Holdings Berhad - 0
RM0.09 Buy/Sell RM0.24 -100.00%
PLABS Stock Forecast PeterLabs Holdings Berhad - 12
RM0.20 Buy/Sell RM0.00 -100.00%

Apex Healthcare Berhad Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Apex Healthcare Berhad's Dividend per Share has decreased from RM0.05 to RM0.04 – a 20.00% drop. In the next year, analysts believe that Dividend per Share will reach RM0.06 – an increase of 50.00%. For the next seven years, the forecast is for Dividend per Share to grow by 59.23%.

2024 DPS Forecast
RM0.06
2025 DPS Forecast
RM0.06
2026 DPS Forecast
RM0.07
2027 DPS Forecast
RM0.06
2028 DPS Forecast
RM0.06
2029 DPS Forecast
RM0.06
2030 DPS Forecast
RM0.06

Apex Healthcare Berhad Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
RM0.07B
2025 FCF Forecast
RM0.07B
2026 FCF Forecast
RM0.07B
2027 FCF Forecast
RM0.07B
2028 FCF Forecast
RM0.07B
2029 FCF Forecast
RM0.07B
2030 FCF Forecast
RM0.07B

Apex Healthcare Berhad EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Apex Healthcare Berhad's EBITDA has grown, moving from RM68.99M to RM90.05M – an increase of 30.53%. In the next year, analysts predict that EBITDA will jump to RM113.53M – up 26.07% from the current level. Looking ahead to seven years, experts forecast that EBITDA will grow by 34.31%.

2024 EBITDA Forecast
RM0.11B
2025 EBITDA Forecast
RM0.12B
2026 EBITDA Forecast
RM0.13B
2027 EBITDA Forecast
RM0.11B
2028 EBITDA Forecast
RM0.11B
2029 EBITDA Forecast
RM0.12B
2030 EBITDA Forecast
RM0.12B

Apex Healthcare Berhad EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Apex Healthcare Berhad's EBIT has seen an increase, rising from RM53.47M to RM72.89M. This represents a growth of 36.32%. Analysts predict that Apex Healthcare Berhad's EBIT will increase in the upcoming year, reaching RM91.90M. This would represent an increase of 26.08%. Over the next seven years, experts predict that Apex Healthcare Berhad's EBIT will grow at a rate of 55.23%.

2024 EBIT Forecast
RM0.09B
2025 EBIT Forecast
RM0.11B
2026 EBIT Forecast
RM0.13B
2027 EBIT Forecast
RM0.11B
2028 EBIT Forecast
RM0.10B
2029 EBIT Forecast
RM0.11B
2030 EBIT Forecast
RM0.11B

Apex Healthcare Berhad EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Apex Healthcare Berhad's EPS has decreased by 100.00%, going from RM0.08 to RM0.00. In the next year, analysts believe that EPS will reach RM0.13 – an increase of 100.00%. For the next seven years, experts predict that Apex Healthcare Berhad's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
RM0.13
2025 EPS Forecast
RM0.14
2026 EPS Forecast
RM0.15
2027 EPS Forecast
RM0.09
2028 EPS Forecast
RM0.11
2029 EPS Forecast
RM0.12
2030 EPS Forecast
RM0.14